I’ll tell you what.
In anti-infection treatment, it is common for some populations to judge the efficacy of a drug only on the basis of past experience. For example, in a parent’s exchange, mention was made that “the last doctor gave our children the Achmycin, a drug that worked better than his head”, while another parent added that the last child had had a fever for a few days and that it worked immediately. Because different anti-infection drugs target different pathogens and areas of infection, antibiotic drug efficacy is not as simple as that.
In the prescription of antibacterial drugs for children in primary health-care institutions, the large ringed esters, the first and third generations of cystasysterin are more common, with the proportion of large esters reaching 40.2 per cent. This is due to the fact that the antibacterial spectrum covers sepsis streptococcus, golden streptococcus, pneumocococcus, haemophilus influenzae, cartamola, chlamydia, etc., which is common in children ‘ s respiratory tracts, or the first drug of choice for sexually pneumonia pneumonia in pre-school and school-age children ‘ s communities, and that the pneumonia streptozophrenia is not uncommon among children aged 1-3 in recent years. However, penicillin and the antibacterial spectrophylls do not cover the pneumonia spectrogen or the pneumonia chlamydia.
For example, in the case of paediatric acute osteoporosis, for its common pathogen A streptocococcus, no anticin A streptococococcus has been detected. Beta-neamamine antibacterial drugs, such as Amosicillin, Amosilin Clavic acid, penicillin, etc., are preferred; for penicillin allergics, two or three generations of streptoacin are available; for persons with an allergy history of β-nemamine antibacterials, the cyclopenetone is optional. And in our country, the A streptocycoccus has a resistance rate of more than 90 per cent for large cyclopentone and clinicillin, and there is a high risk of failure in the choice of drugs such as Archicillin. In the case of lower respiratory infections in children with common pathogen pneumonia, the antibacterials of the Great Ringed ester are the preferred and the β-neamide is not effective. Therefore, the choice of anti-infection drugs needs to be based on scientific grounds such as the infected pathogens and their sensitivity, and the efficacy of the drug cannot be judged by experience alone.
Blind and wind medicine.
In practice, the use of anti-infection drugs by some is blind. For example, parents who hear that their own children have a viral pneumoconiosis (VP) which is the drug that they lose, see their own children with a fever and cough, and feel that their children must be parageny pneumonia and want to use the same antivirals for treatment.
In fact, anti-infection drugs must not be used blindly, and patients must first be diagnosed in a regular medical facility. Accommodatives for antibacterial drugs are available only if they are diagnosed as bacterial, fungi-infected; antibacterial drugs can be applied only if they are related to infections caused by pathogenic microorganisms such as the non-tuberculosis streptocobacteria, chlamydia, chlamydia, helix, lektics and some of the insects. There is no clinical or laboratory evidence of bacterial and the above-mentioned pathogen micro-organisms, and those who cannot be diagnosed, as well as those infected with the virus, have no antibacterial acclimatization. Moreover, the pneumonia trigenes are not viruses and cannot be treated with antivirals. The blind use of anti-infection drugs may increase the use of unnecessary drugs, or may delay treatment because of, for example, the selection of the wrong drugs and even the inducing of resistant micro-organisms.
The more expensive the better or the better the new.
There is a misconception in many quarters that anti-infection drugs are more expensive and better or newer, and that they are always preferred to new and expensive anti-bacterial drugs. For example, when choosing a cure, some patients will take the initiative to ask the doctor to use the most expensive antibacterial drug of his or her highest quality, and feel that it would be better to hurry.
In practice, however, each antibacterial drug has its own characteristics, with different advantages and disadvantages, and its efficacy depends on the strength of the drug ‘ s activity to the fungi, which is not directly related to its age and age and price. For example, erythrin is an old-fashioned antibacterial, cheap, but it has a fairly good effect on the pneumonia that is infected with the Legion of Armaments and the Sphinx, while the price is high for carbon-cyanide. Antiphyllic acids and three-generation cystasy are less effective than erythylene in dealing with these conditions. Moreover, some of the old drugs are more stable and the adverse effects are more clear. New antibacterial drugs are often born because old drugs are resistant and should be used if they are effective for the disease. So, when choosing an anti-infection drug, it is the disease, the person who chooses the appropriate drug, rather than simply looking at the price or the old or the new.